Brief: HCW Biologics Granted Third Fundamental Patent
14/06/2023 12:37
June 14 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS IS GRANTED THIRD FUNDAMENTAL PATENT: U.S.
PATENT
FOR METHODS OF TREATING AGE-RELATED DISORDERS
Source text for Eikon: ID:nGNX4gZdfB
Further company coverage: HCWB.O
(reuters.briefs@thomsonreuters.com)
Recent news on Hcw Biologics
See all newsBrief: Hcw Biologics Maintains Momentum Toward Completion Of Ind Application For Clinical Study To Evaluate Lead T-Cell Engager In Solid Tumors
Brief: HCW Biologics Registers Resale Of Up To 1.81 Mln Shares Of Common Stock By Selling Stockholder- SEC Filing
NASDAQ RESUMED AT 10:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM
NASDAQ RESUMED AT 10:29 AM